A carregar...
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey
A dose non-inferiority study comparing 100 mg, 300 mg and 600 mg of aspirin for cancer prevention among Lynch Syndrome carriers is underway (Colorectal Adenoma/Carcinoma Prevention Programme trial 3, CaPP3). To guide implementation of the findings, we investigated general practitioner (GP) attitudes...
Na minha lista:
| Publicado no: | Fam Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Netherlands
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5603645/ https://ncbi.nlm.nih.gov/pubmed/28434157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-017-9986-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|